Galmed Pharma Balance Sheet - Annual (NASDAQ:GLMD)

Add to My Stocks
$12.61 $0.24 (1.87%) GLMD stock closing price Sep 18, 2018 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our Galmed Pharma stock analysis. A balance sheet can help evaluate the financial performance of a company. Ratios like return on total assets and current ratio, which also uses cash on hand can be used to measure the operating efficiency of a firm, and can be used to conduct a more accurate Galmed Pharma stock analysis. Annual results are typically accompanied with the company releasing financial statements. Galmed Pharma had a long term debt of $- at the end of 2017. To understand the debt servicing capacity of the company, one needs to look at Galmed Pharma operating cash flow and Galmed Pharma revenue also. Galmed Pharma debt to equity ratio is 0.

View latest 10 year balance sheet data to check Galmed Pharma financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201720162015201420132012
Cash13.02M3.09M4.15M23.73M--
Marketable Securities5.97M12.35M18.84M2.25M--
Receivables------
Inventory------
Raw Materials------
Work In Progress------
Finished Goods------
Notes Receivable------
Other Current Assets---6M--
Total Current Assets
19.15M15.73M23.38M32.15M--
Property Plant & Equipment------
Accumulated Depreciation------
Net Property Plant & Equipment
------
Investment & Advances------
Other Non-Current Assets------
Deferred Charges------
Intangibles------
Deposits & Other Assets------
Total Assets
19.64M16.45M24.26M32.92M--
Notes Payable------
Accounts Payable2.27M3.12M2.25M-1.35M-
Current Portion Long-Term Debt------
Current Portion Capital Leases------
Accrued Expenses------
Income Taxes Payable------
Other Current Liabilities1.57M1.45M----
Total Current Liabilities
3.84M4.57M2.54M1.11M1.68M-
Mortgages------
Deferred Taxes/Income------
Convertible Debt-----1.82M
Long-Term Debt------
Non-Current Capital Leases------
Other Long-Term Liabilities------
Total Liabilities
3.84M5.37M2.71M1.51M2.11M2.22M
Minority Interest------
Preferred Stock------
Common Stock Net------
Capital Surplus92.38M75.44M69.08M68.11M--
Retained Earnings-76.61M-64.32M-47.36M-36.74M--
Treasury Stock------
Other Liabilities-0.01M-0.08M-0.2M---
Shareholders Equity15.79M11.07M21.54M31.4M--
Total Liabilities & Shareholders Equity19.64M16.45M24.26M32.92M2.11M2.22M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Most investors just check the Galmed Pharma stock price, and Galmed Pharma historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Galmed Pharma PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: An asset is a resource that a corporation like Galmed Pharma owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for GLMD stock as of 2017 is $19.64M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. GLMD stock had total liabilities of $3.84M for the year 2017.

Galmed Pharma Balance Sheet - Key Ratios

Current ratio
24.86
Debt to equity ratio
0
Asset turnover ratio
0.02
Receivables turnover
4.12
Price to book ratio
7.44